Straumann Holding AG

  • Market Cap: N/A
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: CH1175448666
CHF
95.28
-0.3 (-0.31%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-summaryPrice Point
High/Low

1Day

52 Week

Valuation
Technical
Day's Volume

CASH

413.3 k

Shareholding (Dec 2023)

FII

0.03%

Held by 4 FIIs

DII

99.97%

Held by 0 DIIs

Promoter

0.00%

iScoreScore
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy

MarketsMojo — Loved in India, Now Global

The power of Mojo is now in 29 countries. Explore global equities with the same cutting-edge features you love.

Dashboard
1

High Management Efficiency with a high ROE of 21.47%

 
2

Company's ability to service its debt is strong with a healthy EBIT to Interest (avg) ratio of 25.81

 
3

Healthy long term growth as Net Sales has grown by an annual rate of 9.40% and Operating profit at 7.92%

 
4

Flat results in Jun 25

5

With ROE of 12.03%, it has a Very Expensive valuation with a 6.80 Price to Book Value

6

Below par performance in long term as well as near term

stock-summaryMojo Parameters
Mojo Parameters
Stock DNA
stock-summary
Industry

Pharmaceuticals & Biotechnology

stock-summary
Market cap

CHF 14,670 Million ()

stock-summary
P/E

56.00

stock-summary
Industry P/E

NA

stock-summary
Dividend Yield

1.03%

stock-summary
Debt Equity

-0.05

stock-summary
Return on Equity

12.03%

stock-summary
Price to Book

7.13

Revenue and Profits:
Net Sales:
(Quarterly Results - )
Net Profit:
stock-summaryTotal Returns
Total Returns (Price + Dividend) stock-summary
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
3.57%
0%
3.57%
6 Months
-11.41%
0%
-11.41%
1 Year
-19.19%
0%
-19.19%
2 Years
-21.45%
0%
-21.45%
3 Years
-13.03%
0%
-13.03%
4 Years
-53.52%
0%
-53.52%
5 Years
-5.9%
0%
-5.9%

Straumann Holding AG for the last several years.

Risk Adjusted Returns v/s stock-summary
stock-summaryNews & Corporate Actions
News
Icon
No Recent News for the Company
Announcements stock-summary
Icon
No announcement available
Corporate Actions stock-summary
Icon
No corporate action available
stock-summaryKey Factors
Quality key factors stock-summary
Factor
Value
Sales Growth (5y)
9.40%
EBIT Growth (5y)
7.92%
EBIT to Interest (avg)
25.81
Debt to EBITDA (avg)
0
Net Debt to Equity (avg)
-0.08
Sales to Capital Employed (avg)
0.99
Tax Ratio
27.86%
Dividend Payout Ratio
39.17%
Pledged Shares
0
Institutional Holding
0.03%
ROCE (avg)
32.57%
ROE (avg)
21.47%
Valuation key factors
Factor
Value
P/E Ratio
56
Industry P/E
Price to Book Value
6.80
EV to EBIT
35.08
EV to EBITDA
19.38
EV to Capital Employed
6.31
EV to Sales
5.66
PEG Ratio
26.82
Dividend Yield
1.08%
ROCE (Latest)
17.99%
ROE (Latest)
12.03%
Technicals key factors
Indicator
Weekly
Monthly
MACD
Mildly Bullish
Bearish
RSI
No Signal
No Signal
Bollinger Bands
Bullish
Mildly Bearish
Moving Averages
Mildly Bearish (Daily)
KST
Mildly Bullish
Bearish
Dow Theory
Mildly Bearish
Mildly Bullish
OBV
Mildly Bearish
Mildly Bearish
stock-summary Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
stock-summaryShareholding
Shareholding Snapshot : Dec 2023stock-summary
Shareholding Compare (%holding) stock-summary
Majority shareholders

Foreign Institutions

Domestic Funds

Held in 0 Schemes (0%)

Foreign Institutions

Held by 4 Foreign Institutions (0.03%)

Strategic Entities with highest holding

Highest Public shareholder

stock-summaryFinancial
[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "alert": "No Quarterly Results declared by Straumann Holding AG"
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "header": "Annual Results Snapshot (Consolidated) - Dec'24",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in year ended Dec 2024 is 3.82% vs 3.92% in Dec 2023",
        "dir": -1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in year ended Dec 2024 is 86.18% vs -43.24% in Dec 2023",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Dec'24",
        "Dec'23",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "2,503.90",
          "val2": "2,411.80",
          "chgp": "3.82%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "731.00",
          "val2": "534.10",
          "chgp": "36.87%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "21.00",
          "val2": "17.90",
          "chgp": "17.32%",
          "chgp_class": "negative"
        },
        {
          "field": "Exceptional Items",
          "val1": "-2.60",
          "val2": "-1.90",
          "chgp": "-36.84%",
          "chgp_class": "negative"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "459.50",
          "val2": "246.80",
          "chgp": "86.18%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "234.00%",
          "val2": "167.50%",
          "chgp": "6.65%",
          "chgp_class": "positive"
        }
      ]
    }
  }
]
Annual Results Snapshot (Consolidated) - Dec'24stock-summary
Dec'24
Dec'23
Change(%)
Net Sales
2,503.90
2,411.80
3.82%
Operating Profit (PBDIT) excl Other Income
731.00
534.10
36.87%
Interest
21.00
17.90
17.32%
Exceptional Items
-2.60
-1.90
-36.84%
Consolidate Net Profit
459.50
246.80
86.18%
Operating Profit Margin (Excl OI)
234.00%
167.50%
6.65%
USD in Million.
Direction Arrows
Net Sales

YoY Growth in year ended Dec 2024 is 3.82% vs 3.92% in Dec 2023

Direction Arrows
Consolidated Net Profit

YoY Growth in year ended Dec 2024 is 86.18% vs -43.24% in Dec 2023

stock-summaryCompany CV
About Straumann Holding AG stock-summary
stock-summary
Straumann Holding AG
Pharmaceuticals & Biotechnology
Straumann Holding AG is a Switzerland-based company active in the field of implant and restorative dentistry and oral tissue regeneration. In collaboration with clinics, research institutes and universities, the Group researches and develops implants, instruments, computer-aided design/manufacturing (CAD/CAM) prosthetics and tissue regeneration products for use in tooth replacement and restoration solutions or to prevent tooth loss. Straumann Holding AG also offers a range of services to the dental profession worldwide, including training and education, provided in collaboration with the International Team for Implantology (ITI). Its products and services are available in a number of countries through the Group’s headquarters and through a network of subsidiaries and technology partners located in Europe, North America, the Asia/Pacific region and in Latin America, including Dental Wings Inc based in Canada and Createch Medical SL based in Spain.
Company Coordinates stock-summary
Company Details
Peter Merian-Weg 12 , BASEL None : 4002
stock-summary
Tel: 41 61 9651111
stock-summary
Registrar Details